AICAr, a Widely Used AMPK Activator with Important AMPK-Independent Effects: A Systematic Review

por Višnjić, Dora, Lalić, Hrvoje, Dembitz, Vilma, Tomić, Barbara, Smoljo, Tomislav
Publicado 2021

The ribonucleoside AICAr induces differentiation of myeloid leukemia by activating the ATR/Chk1 via pyrimidine depletion

por Dembitz, Vilma, Tomic, Barbara, Kodvanj, Ivan, Simon, Julian A., Bedalov, Antonio, Visnjic, Dora
Publicado 2019

Bone marrow stromal cells reduce low-dose cytarabine-induced differentiation of acute myeloid leukemia

por Smoljo, Tomislav, Tomic, Barbara, Lalic, Hrvoje, Dembitz, Vilma, Batinic, Josip, Bedalov, Antonio, Visnjic, Dora
Publicado 2023

Cytarabine-induced differentiation of AML cells depends on Chk1 activation and shares the mechanism with inhibitors of DHODH and pyrimidine synthesis

por Tomic, Barbara, Smoljo, Tomislav, Lalic, Hrvoje, Dembitz, Vilma, Batinic, Josip, Batinic, Drago, Bedalov, Antonio, Visnjic, Dora
Publicado 2022

5-aminoimidazole-4-carboxamide ribonucleoside induces differentiation in a subset of primary acute myeloid leukemia blasts

por Dembitz, Vilma, Lalic, Hrvoje, Kodvanj, Ivan, Tomic, Barbara, Batinic, Josip, Dubravcic, Klara, Batinic, Drago, Bedalov, Antonio, Visnjic, Dora
Publicado 2020